INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/13/2024
Back to search
Official data from USPTO
PHYTOMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
01/13/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
04/06/2021
Registration date
08/09/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/09/2022
Last transaction
08/09/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
WOLFE, YOUNG J
Law office
N40
Current location
TMO LAW OFFICE 122
Mark description
The mark consists of the word "PHYTOMAB" colored blue. The figures of split leaf consist of right upper part gradated green to light green and left lower part gradated blue to light blue. The color white appears along the line of leaf veins.
Holders and representatives
Holders
PHYTOMAB CO., LTD.
Representatives
Kisuk Lee Harness, Dickey & Pierce, PLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for the treatment of canceranticancer medicines; biological preparations for medicalpharmaceutical and veterinary purposesbiological preparations for treatment of cancer; proteins for medicalpharmaceutical and veterinary purposesprotein arrays for medical diagnosis purposes; biological vectors for medicalpharmaceutical and veterinary purposesviral vectors for treatment of cancer; preparations of transformation microorganisms for medicalpharmaceutical and veterinary purposesfor the treatment of cancer; preparations of microorganisms for medicalpharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; preparations of gene recombination for medicalpharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medicalpharmaceutical and veterinary purposes; cell lines for medicalpharmaceutical and veterinary purposes; medicalpharmaceutical and veterinary preparations for the treatment of cells; stem cells for medicalpharmaceutical and veterinary purposes; vaccines for medicalpharmaceutical and veterinary purposes; antibiotics for medicalpharmaceutical and veterinary purposes; anti-cancer preparations for medicalpharmaceutical and veterinary purposes; nucleic acid sequences for medicalpharmaceutical and veterinary purposes; biopharmaceuticals for treatment of hepatitis; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of auto-immune diseases
Class 42
pharmaceutical research and development; chemistry serviceschemical analysis; synthetic biology servicesresearch and analysis in the field of synthetic biology; stem cells biology servicesresearch and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; laboratory research services relating to pharmaceuticals; testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medicalpharmacological and veterinary science; laboratory research in the field of pharmaceuticalsbiologybiochemistry and chemistry; research and development services in the field of microorganisms and cells technology; research services in the field of chemistrybiochemistryenzymologybiologycell biology and biotechnology
Publications
History of USPTO decisions and trademark events.
37 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/03/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/09/2023
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/06/2023
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
05/03/2023
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/03/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/18/2022
FIMP
FINAL DISPOSITION PROCESSED
11/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/24/2022
PUBO
PUBLISHED FOR OPPOSITION
05/24/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2022
RFNT
REFUSAL PROCESSED BY IB
01/15/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/27/2021
RFRR
REFUSAL PROCESSED BY MPU
12/27/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/30/2021
CNRT
NON-FINAL ACTION WRITTEN
11/29/2021
DOCK
ASSIGNED TO EXAMINER
11/22/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/22/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/17/2021
Continuous trademark protection
Get notified about every new filing that threatens PHYTOMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.